SCHEMBL31240430

SCHEMBL31240430

Nc1n[nH]c2ccc(-c3ccnc4[nH]c(-c5ccnc(NCc6ccccc6)c5)cc34)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 4/20 0.48
▸ CDK2 P24941 4/20 0.48
▸ CCNE1 P24864 1/20 0.48
▸ DBF4 Q9UBU7 1/20 0.48
▸ DYRK1A Q13627 7/20 0.47
▸ CLK2 P49760 6/20 0.47
▸ CLK3 P49761 4/20 0.47
▸ JAK2 O60674 6/20 0.43
▸ EGFR P00533 5/20 0.42
▸ JAK3 P52333 3/20 0.42
▸ ROCK2 O75116 3/20 0.42
▸ PRKACA P17612 3/20 0.42
▸ KDR P35968 3/20 0.42
▸ GSK3B P49841 3/20 0.42
▸ AURKB Q96GD4 3/20 0.42
▸ AURKA O14965 2/20 0.42
▸ MAPK13 O15264 2/20 0.42
▸ DAPK3 O43293 2/20 0.42
▸ CHEK2 O96017 2/20 0.42
▸ PRKCG P05129 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240622 0.90 DYRK1A (0.48) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240570 0.86 DYRK1A (0.48) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240411 0.86 CDC7 (0.58) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240405 0.85 CLK2 (0.59) DYRK1ACLK2CLK3JAK2EGFR
SCHEMBL31240700 0.85 CLK2 (0.58) DYRK1ACLK2CLK3JAK2JAK3
SCHEMBL31240550 0.85 DYRK1A (0.51) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240503 0.84 PRMT5 (0.47) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240301 0.83 DYRK1A (0.46) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240357 0.83 DYRK1A (0.45) CDC7CDK2CCNE1DBF4DYRK1A
SCHEMBL31240343 0.81 CLK2 (0.63) DYRK1ACLK2CLK3JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback